06/29/2025
💉 GLP-1s: More Than a Blood Sugar Story
Ozempic, Wegovy, and Mounjaro aren’t just making headlines for weight loss anymore—they’re stepping into the ring as contenders in cardiovascular disease prevention. 📉❤️
Recent trials like SELECT and SUSTAIN-6 show these drugs can reduce heart attacks, strokes, and cardiovascular death—even in patients without diabetes.
But let’s not get carried away. SGLT-2s still outperform in heart failure. GLP-1s shine in stroke prevention for diabetics with heart disease. This isn’t one-size-fits-all—it’s precision prescribing.
🔍 As GLP-1 popularity soars, clinical discernment and payer oversight matter more than ever. This is where we come in. https://www.prodigycareservices.com/blog/are-glp-1s